AXIM Biotechnologies, Inc.
AXIM Biotechnologies, Inc. AXIM Peers
See (AXIM) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AXIM | $0.01 | +16.28% | 2.1M | -0.35 | -$0.02 | N/A |
| NONOF | $69.49 | +0.75% | 308.5B | 19.20 | $3.62 | +2.39% |
| CSLLY | $79.96 | +0.99% | 154.9B | 29.40 | $2.72 | +1.66% |
| CMXHF | $152.73 | +1.13% | 74B | 28.02 | $5.45 | +1.81% |
| UCBJF | $199.84 | -0.03% | 38B | 31.77 | $6.29 | +0.79% |
| UCBJY | $96.19 | -2.12% | 36.6B | 30.54 | $3.15 | +0.82% |
| ARGNF | $547.60 | +0.08% | 33.4B | 33.35 | $16.42 | N/A |
| ODTC | $22,005.00 | +29.44% | 24.1B | 1.07 | $20,580.00 | N/A |
| IVBXF | $10.50 | +2.54% | 17.3B | -1050.00 | -$0.01 | N/A |
| WXXWY | $6.45 | +0.08% | 13.3B | 29.32 | $0.22 | N/A |
Stock Comparison
AXIM vs NONOF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, NONOF has a market cap of 308.5B. Regarding current trading prices, AXIM is priced at $0.01, while NONOF trades at $69.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas NONOF's P/E ratio is 19.20. In terms of profitability, AXIM's ROE is +0.38%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, AXIM is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs CSLLY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CSLLY has a market cap of 154.9B. Regarding current trading prices, AXIM is priced at $0.01, while CSLLY trades at $79.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CSLLY's P/E ratio is 29.40. In terms of profitability, AXIM's ROE is +0.38%, compared to CSLLY's ROE of +0.26%. Regarding short-term risk, AXIM is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs CMXHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CMXHF has a market cap of 74B. Regarding current trading prices, AXIM is priced at $0.01, while CMXHF trades at $152.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CMXHF's P/E ratio is 28.02. In terms of profitability, AXIM's ROE is +0.38%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, AXIM is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs UCBJF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, UCBJF has a market cap of 38B. Regarding current trading prices, AXIM is priced at $0.01, while UCBJF trades at $199.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas UCBJF's P/E ratio is 31.77. In terms of profitability, AXIM's ROE is +0.38%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, AXIM is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs UCBJY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, UCBJY has a market cap of 36.6B. Regarding current trading prices, AXIM is priced at $0.01, while UCBJY trades at $96.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas UCBJY's P/E ratio is 30.54. In terms of profitability, AXIM's ROE is +0.38%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, AXIM is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ARGNF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ARGNF has a market cap of 33.4B. Regarding current trading prices, AXIM is priced at $0.01, while ARGNF trades at $547.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ARGNF's P/E ratio is 33.35. In terms of profitability, AXIM's ROE is +0.38%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, AXIM is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ODTC Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, AXIM is priced at $0.01, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ODTC's P/E ratio is 1.07. In terms of profitability, AXIM's ROE is +0.38%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, AXIM is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs IVBXF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, IVBXF has a market cap of 17.3B. Regarding current trading prices, AXIM is priced at $0.01, while IVBXF trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas IVBXF's P/E ratio is -1050.00. In terms of profitability, AXIM's ROE is +0.38%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, AXIM is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs WXXWY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, WXXWY has a market cap of 13.3B. Regarding current trading prices, AXIM is priced at $0.01, while WXXWY trades at $6.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas WXXWY's P/E ratio is 29.32. In terms of profitability, AXIM's ROE is +0.38%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, AXIM is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs WXIBF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, WXIBF has a market cap of 12.9B. Regarding current trading prices, AXIM is priced at $0.01, while WXIBF trades at $3.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas WXIBF's P/E ratio is 28.91. In terms of profitability, AXIM's ROE is +0.38%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, AXIM is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs GNMSF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, GNMSF has a market cap of 12.5B. Regarding current trading prices, AXIM is priced at $0.01, while GNMSF trades at $203.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas GNMSF's P/E ratio is 11.91. In terms of profitability, AXIM's ROE is +0.38%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, AXIM is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs SBMFF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SBMFF has a market cap of 12.2B. Regarding current trading prices, AXIM is priced at $0.01, while SBMFF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SBMFF's P/E ratio is 68.20. In terms of profitability, AXIM's ROE is +0.38%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, AXIM is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs SBHMY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SBHMY has a market cap of 8.5B. Regarding current trading prices, AXIM is priced at $0.01, while SBHMY trades at $9.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, AXIM's ROE is +0.38%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, AXIM is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs TRSBF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, TRSBF has a market cap of 7.8B. Regarding current trading prices, AXIM is priced at $0.01, while TRSBF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas TRSBF's P/E ratio is 27.50. In terms of profitability, AXIM's ROE is +0.38%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, AXIM is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs AKBLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, AKBLF has a market cap of 6.3B. Regarding current trading prices, AXIM is priced at $0.01, while AKBLF trades at $28.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas AKBLF's P/E ratio is 42.73. In terms of profitability, AXIM's ROE is +0.38%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, AXIM is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs TLPPF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, TLPPF has a market cap of 5.5B. Regarding current trading prices, AXIM is priced at $0.01, while TLPPF trades at $16.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas TLPPF's P/E ratio is 181.67. In terms of profitability, AXIM's ROE is +0.38%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, AXIM is less volatile compared to TLPPF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs ABCZF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, AXIM is priced at $0.01, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, AXIM's ROE is +0.38%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, AXIM is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs INCPF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, AXIM is priced at $0.01, while INCPF trades at $3.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas INCPF's P/E ratio is -108.67. In terms of profitability, AXIM's ROE is +0.38%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, AXIM is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs GNNSF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, GNNSF has a market cap of 4.7B. Regarding current trading prices, AXIM is priced at $0.01, while GNNSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas GNNSF's P/E ratio is -27.50. In terms of profitability, AXIM's ROE is +0.38%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, AXIM is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs LABFF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, AXIM is priced at $0.01, while LABFF trades at $90.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas LABFF's P/E ratio is 28.95. In terms of profitability, AXIM's ROE is +0.38%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, AXIM is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ZLDPF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ZLDPF has a market cap of 4.1B. Regarding current trading prices, AXIM is priced at $0.01, while ZLDPF trades at $57.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ZLDPF's P/E ratio is -21.39. In terms of profitability, AXIM's ROE is +0.38%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, AXIM is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs CAMRF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CAMRF has a market cap of 3.7B. Regarding current trading prices, AXIM is priced at $0.01, while CAMRF trades at $63.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CAMRF's P/E ratio is 64.95. In terms of profitability, AXIM's ROE is +0.38%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, AXIM is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs REGMF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, AXIM is priced at $0.01, while REGMF trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas REGMF's P/E ratio is -13.32. In terms of profitability, AXIM's ROE is +0.38%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, AXIM is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs SHJBF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SHJBF has a market cap of 3.1B. Regarding current trading prices, AXIM is priced at $0.01, while SHJBF trades at $1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, AXIM's ROE is +0.38%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, AXIM is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs TKBIF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, AXIM is priced at $0.01, while TKBIF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, AXIM's ROE is +0.38%, compared to TKBIF's ROE of N/A. Regarding short-term risk, AXIM is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs MPSYF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, AXIM is priced at $0.01, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, AXIM's ROE is +0.38%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, AXIM is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs BVNKF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, AXIM is priced at $0.01, while BVNKF trades at $26.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BVNKF's P/E ratio is 10.37. In terms of profitability, AXIM's ROE is +0.38%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, AXIM is more volatile compared to BVNKF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs BVNRY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BVNRY has a market cap of 2.1B. Regarding current trading prices, AXIM is priced at $0.01, while BVNRY trades at $8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BVNRY's P/E ratio is 10.28. In terms of profitability, AXIM's ROE is +0.38%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, AXIM is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ASPHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ASPHF has a market cap of 2B. Regarding current trading prices, AXIM is priced at $0.01, while ASPHF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ASPHF's P/E ratio is -32.36. In terms of profitability, AXIM's ROE is +0.38%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, AXIM is less volatile compared to ASPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs BTTAY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, AXIM is priced at $0.01, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, AXIM's ROE is +0.38%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, AXIM is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs GLPGF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, AXIM is priced at $0.01, while GLPGF trades at $28.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas GLPGF's P/E ratio is -9.15. In terms of profitability, AXIM's ROE is +0.38%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, AXIM is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ONTTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ONTTF has a market cap of 1.9B. Regarding current trading prices, AXIM is priced at $0.01, while ONTTF trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ONTTF's P/E ratio is -9.33. In terms of profitability, AXIM's ROE is +0.38%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, AXIM is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs BRCTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, AXIM is priced at $0.01, while BRCTF trades at $19.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BRCTF's P/E ratio is 18.42. In terms of profitability, AXIM's ROE is +0.38%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, AXIM is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs GENSF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, GENSF has a market cap of 1.7B. Regarding current trading prices, AXIM is priced at $0.01, while GENSF trades at $26.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas GENSF's P/E ratio is -325.12. In terms of profitability, AXIM's ROE is +0.38%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, AXIM is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs PPTDF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PPTDF has a market cap of 1.7B. Regarding current trading prices, AXIM is priced at $0.01, while PPTDF trades at $13.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PPTDF's P/E ratio is 16.68. In terms of profitability, AXIM's ROE is +0.38%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, AXIM is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs BIESF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BIESF has a market cap of 1.7B. Regarding current trading prices, AXIM is priced at $0.01, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BIESF's P/E ratio is -44.44. In terms of profitability, AXIM's ROE is +0.38%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, AXIM is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs PHMMF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PHMMF has a market cap of 1.6B. Regarding current trading prices, AXIM is priced at $0.01, while PHMMF trades at $92.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PHMMF's P/E ratio is 70.13. In terms of profitability, AXIM's ROE is +0.38%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, AXIM is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs BRAXF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, AXIM is priced at $0.01, while BRAXF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, AXIM's ROE is +0.38%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, AXIM is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs CSBTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CSBTF has a market cap of 1.3B. Regarding current trading prices, AXIM is priced at $0.01, while CSBTF trades at $34.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CSBTF's P/E ratio is -283.33. In terms of profitability, AXIM's ROE is +0.38%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, AXIM is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs MEOBF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, MEOBF has a market cap of 1.2B. Regarding current trading prices, AXIM is priced at $0.01, while MEOBF trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas MEOBF's P/E ratio is -16.17. In terms of profitability, AXIM's ROE is +0.38%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, AXIM is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ASCLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ASCLF has a market cap of 1.2B. Regarding current trading prices, AXIM is priced at $0.01, while ASCLF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ASCLF's P/E ratio is -31.37. In terms of profitability, AXIM's ROE is +0.38%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, AXIM is less volatile compared to ASCLF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs NURPF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, AXIM is priced at $0.01, while NURPF trades at $8.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas NURPF's P/E ratio is 12.41. In terms of profitability, AXIM's ROE is +0.38%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, AXIM is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs HBMHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, HBMHF has a market cap of 931.6M. Regarding current trading prices, AXIM is priced at $0.01, while HBMHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas HBMHF's P/E ratio is 36.67. In terms of profitability, AXIM's ROE is +0.38%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, AXIM is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs PHGUF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PHGUF has a market cap of 782.4M. Regarding current trading prices, AXIM is priced at $0.01, while PHGUF trades at $1.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PHGUF's P/E ratio is -57.50. In terms of profitability, AXIM's ROE is +0.38%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, AXIM is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs BPMUF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BPMUF has a market cap of 752.8M. Regarding current trading prices, AXIM is priced at $0.01, while BPMUF trades at $61.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BPMUF's P/E ratio is 8.32. In terms of profitability, AXIM's ROE is +0.38%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, AXIM is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs CSPHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CSPHF has a market cap of 703M. Regarding current trading prices, AXIM is priced at $0.01, while CSPHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, AXIM's ROE is +0.38%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, AXIM is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs SOLTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SOLTF has a market cap of 597.3M. Regarding current trading prices, AXIM is priced at $0.01, while SOLTF trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SOLTF's P/E ratio is -36.67. In terms of profitability, AXIM's ROE is +0.38%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, AXIM is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs BXPHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BXPHF has a market cap of 568.7M. Regarding current trading prices, AXIM is priced at $0.01, while BXPHF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BXPHF's P/E ratio is -29.00. In terms of profitability, AXIM's ROE is +0.38%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, AXIM is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs INRLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, INRLF has a market cap of 527.2M. Regarding current trading prices, AXIM is priced at $0.01, while INRLF trades at $3.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas INRLF's P/E ratio is -4.84. In terms of profitability, AXIM's ROE is +0.38%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, AXIM is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs IDRSF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, IDRSF has a market cap of 505.8M. Regarding current trading prices, AXIM is priced at $0.01, while IDRSF trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas IDRSF's P/E ratio is -1.45. In terms of profitability, AXIM's ROE is +0.38%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, AXIM is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs CKDXF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CKDXF has a market cap of 485.2M. Regarding current trading prices, AXIM is priced at $0.01, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, AXIM's ROE is +0.38%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, AXIM is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs SNBIF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SNBIF has a market cap of 471.7M. Regarding current trading prices, AXIM is priced at $0.01, while SNBIF trades at $6.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, AXIM's ROE is +0.38%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, AXIM is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs AAVXF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, AAVXF has a market cap of 461.9M. Regarding current trading prices, AXIM is priced at $0.01, while AAVXF trades at $7.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas AAVXF's P/E ratio is -2.11. In terms of profitability, AXIM's ROE is +0.38%, compared to AAVXF's ROE of -2.11%. Regarding short-term risk, AXIM is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs TBGNF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, AXIM is priced at $0.01, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, AXIM's ROE is +0.38%, compared to TBGNF's ROE of N/A. Regarding short-term risk, AXIM is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs VBIZF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, VBIZF has a market cap of 411.9M. Regarding current trading prices, AXIM is priced at $0.01, while VBIZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas VBIZF's P/E ratio is 19.80. In terms of profitability, AXIM's ROE is +0.38%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, AXIM is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs PTCHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PTCHF has a market cap of 396.8M. Regarding current trading prices, AXIM is priced at $0.01, while PTCHF trades at $1.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PTCHF's P/E ratio is 7.87. In terms of profitability, AXIM's ROE is +0.38%, compared to PTCHF's ROE of +0.15%. Regarding short-term risk, AXIM is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs CLVLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CLVLF has a market cap of 361.9M. Regarding current trading prices, AXIM is priced at $0.01, while CLVLF trades at $7.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CLVLF's P/E ratio is 14.44. In terms of profitability, AXIM's ROE is +0.38%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, AXIM is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs NWBO Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, NWBO has a market cap of 358.2M. Regarding current trading prices, AXIM is priced at $0.01, while NWBO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas NWBO's P/E ratio is -4.14. In terms of profitability, AXIM's ROE is +0.38%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, AXIM is more volatile compared to NWBO. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs CYDY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CYDY has a market cap of 351.2M. Regarding current trading prices, AXIM is priced at $0.01, while CYDY trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CYDY's P/E ratio is -14.25. In terms of profitability, AXIM's ROE is +0.38%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, AXIM is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs CLTEF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CLTEF has a market cap of 351M. Regarding current trading prices, AXIM is priced at $0.01, while CLTEF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CLTEF's P/E ratio is -4.91. In terms of profitability, AXIM's ROE is +0.38%, compared to CLTEF's ROE of -0.43%. Regarding short-term risk, AXIM is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs CLVLY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CLVLY has a market cap of 350.4M. Regarding current trading prices, AXIM is priced at $0.01, while CLVLY trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CLVLY's P/E ratio is 13.96. In terms of profitability, AXIM's ROE is +0.38%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, AXIM is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs IVEVF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, IVEVF has a market cap of 317.2M. Regarding current trading prices, AXIM is priced at $0.01, while IVEVF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas IVEVF's P/E ratio is -0.66. In terms of profitability, AXIM's ROE is +0.38%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, AXIM is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs PBBIF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, AXIM is priced at $0.01, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, AXIM's ROE is +0.38%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, AXIM is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs HLOSF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, HLOSF has a market cap of 282.6M. Regarding current trading prices, AXIM is priced at $0.01, while HLOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas HLOSF's P/E ratio is -8.71. In terms of profitability, AXIM's ROE is +0.38%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, AXIM is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs PRRUF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PRRUF has a market cap of 277.5M. Regarding current trading prices, AXIM is priced at $0.01, while PRRUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PRRUF's P/E ratio is -9.50. In terms of profitability, AXIM's ROE is +0.38%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, AXIM is less volatile compared to PRRUF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs HNSBF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, HNSBF has a market cap of 254.3M. Regarding current trading prices, AXIM is priced at $0.01, while HNSBF trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, AXIM's ROE is +0.38%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, AXIM is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs ORYZF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ORYZF has a market cap of 249.8M. Regarding current trading prices, AXIM is priced at $0.01, while ORYZF trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ORYZF's P/E ratio is -53.72. In terms of profitability, AXIM's ROE is +0.38%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, AXIM is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs NWPHF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, AXIM is priced at $0.01, while NWPHF trades at $12.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas NWPHF's P/E ratio is N/A. In terms of profitability, AXIM's ROE is +0.38%, compared to NWPHF's ROE of N/A. Regarding short-term risk, AXIM is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs MDCLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, AXIM is priced at $0.01, while MDCLF trades at $6.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, AXIM's ROE is +0.38%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, AXIM is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs SLNCF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SLNCF has a market cap of 226.7M. Regarding current trading prices, AXIM is priced at $0.01, while SLNCF trades at $1.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SLNCF's P/E ratio is -3.14. In terms of profitability, AXIM's ROE is +0.38%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, AXIM is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs BOVNF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, AXIM is priced at $0.01, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BOVNF's P/E ratio is -4.44. In terms of profitability, AXIM's ROE is +0.38%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, AXIM is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs RAONF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, RAONF has a market cap of 212M. Regarding current trading prices, AXIM is priced at $0.01, while RAONF trades at $1.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas RAONF's P/E ratio is -20.33. In terms of profitability, AXIM's ROE is +0.38%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, AXIM is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs FPHAF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, AXIM is priced at $0.01, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, AXIM's ROE is +0.38%, compared to FPHAF's ROE of N/A. Regarding short-term risk, AXIM is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs VSBC Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, AXIM is priced at $0.01, while VSBC trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas VSBC's P/E ratio is N/A. In terms of profitability, AXIM's ROE is +0.38%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, AXIM is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs FGHQF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, AXIM is priced at $0.01, while FGHQF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, AXIM's ROE is +0.38%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, AXIM is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs BSEM Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BSEM has a market cap of 195.1M. Regarding current trading prices, AXIM is priced at $0.01, while BSEM trades at $11.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BSEM's P/E ratio is -20.95. In terms of profitability, AXIM's ROE is +0.38%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, AXIM is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs BRIBF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, BRIBF has a market cap of 190.3M. Regarding current trading prices, AXIM is priced at $0.01, while BRIBF trades at $0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas BRIBF's P/E ratio is -2.60. In terms of profitability, AXIM's ROE is +0.38%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, AXIM is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs SPHDF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SPHDF has a market cap of 189.9M. Regarding current trading prices, AXIM is priced at $0.01, while SPHDF trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SPHDF's P/E ratio is -3.28. In terms of profitability, AXIM's ROE is +0.38%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, AXIM is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs NGENF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, NGENF has a market cap of 185M. Regarding current trading prices, AXIM is priced at $0.01, while NGENF trades at $2.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas NGENF's P/E ratio is -9.07. In terms of profitability, AXIM's ROE is +0.38%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, AXIM is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs IPHYF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, IPHYF has a market cap of 179.7M. Regarding current trading prices, AXIM is priced at $0.01, while IPHYF trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas IPHYF's P/E ratio is -2.79. In terms of profitability, AXIM's ROE is +0.38%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, AXIM is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs GNFTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, GNFTF has a market cap of 176.3M. Regarding current trading prices, AXIM is priced at $0.01, while GNFTF trades at $3.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, AXIM's ROE is +0.38%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, AXIM is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs ADOCY Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, AXIM is priced at $0.01, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, AXIM's ROE is +0.38%, compared to ADOCY's ROE of +1.73%. Regarding short-term risk, AXIM is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs OPORF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, AXIM is priced at $0.01, while OPORF trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas OPORF's P/E ratio is 12.00. In terms of profitability, AXIM's ROE is +0.38%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, AXIM is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs MLLCF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, AXIM is priced at $0.01, while MLLCF trades at $4.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas MLLCF's P/E ratio is -1.99. In terms of profitability, AXIM's ROE is +0.38%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, AXIM is less volatile compared to MLLCF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs AVCTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, AVCTF has a market cap of 155.1M. Regarding current trading prices, AXIM is priced at $0.01, while AVCTF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, AXIM's ROE is +0.38%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, AXIM is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs SCNLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, SCNLF has a market cap of 135.3M. Regarding current trading prices, AXIM is priced at $0.01, while SCNLF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas SCNLF's P/E ratio is -4.35. In terms of profitability, AXIM's ROE is +0.38%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, AXIM is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs AAPGV Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, AXIM is priced at $0.01, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas AAPGV's P/E ratio is N/A. In terms of profitability, AXIM's ROE is +0.38%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, AXIM is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs AMGXF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, AMGXF has a market cap of 127.1M. Regarding current trading prices, AXIM is priced at $0.01, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, AXIM's ROE is +0.38%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, AXIM is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs PSTTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, AXIM is priced at $0.01, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, AXIM's ROE is +0.38%, compared to PSTTF's ROE of N/A. Regarding short-term risk, AXIM is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs EPRXF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, AXIM is priced at $0.01, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, AXIM's ROE is +0.38%, compared to EPRXF's ROE of -0.85%. Regarding short-term risk, AXIM is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs ADOIF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, AXIM is priced at $0.01, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, AXIM's ROE is +0.38%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, AXIM is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs JWCTF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, JWCTF has a market cap of 101.3M. Regarding current trading prices, AXIM is priced at $0.01, while JWCTF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas JWCTF's P/E ratio is -1.25. In terms of profitability, AXIM's ROE is +0.38%, compared to JWCTF's ROE of -0.47%. Regarding short-term risk, AXIM is more volatile compared to JWCTF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs TRGNF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, AXIM is priced at $0.01, while TRGNF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, AXIM's ROE is +0.38%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, AXIM is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs CMVLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, CMVLF has a market cap of 90.1M. Regarding current trading prices, AXIM is priced at $0.01, while CMVLF trades at $1.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas CMVLF's P/E ratio is -1.87. In terms of profitability, AXIM's ROE is +0.38%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, AXIM is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs MCURF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, AXIM is priced at $0.01, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas MCURF's P/E ratio is -16.90. In terms of profitability, AXIM's ROE is +0.38%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, AXIM is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs ACHFF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, ACHFF has a market cap of 85.9M. Regarding current trading prices, AXIM is priced at $0.01, while ACHFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas ACHFF's P/E ratio is -43.33. In terms of profitability, AXIM's ROE is +0.38%, compared to ACHFF's ROE of +0.53%. Regarding short-term risk, AXIM is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs PBIGF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, PBIGF has a market cap of 84.4M. Regarding current trading prices, AXIM is priced at $0.01, while PBIGF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas PBIGF's P/E ratio is -7.22. In terms of profitability, AXIM's ROE is +0.38%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, AXIM is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for AXIM.
AXIM vs MSCLF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, MSCLF has a market cap of 83M. Regarding current trading prices, AXIM is priced at $0.01, while MSCLF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas MSCLF's P/E ratio is 2.61. In terms of profitability, AXIM's ROE is +0.38%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, AXIM is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.
AXIM vs KNTPF Comparison
AXIM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AXIM stands at 2.1M. In comparison, KNTPF has a market cap of 77M. Regarding current trading prices, AXIM is priced at $0.01, while KNTPF trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AXIM currently has a P/E ratio of -0.35, whereas KNTPF's P/E ratio is -3.55. In terms of profitability, AXIM's ROE is +0.38%, compared to KNTPF's ROE of -4.62%. Regarding short-term risk, AXIM is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for AXIM.